Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-25-038731

SVP, Head of Finance & Admin. sold 1,343 shares at $11.38 ($15,283)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Scalzo Richard William SVP, Head of Finance & Admin. 2025-03-11 Sale 10b5-1 −1,343 $11.38 $15,283 122,330 D
Open-market sales · 1,343 sh · avg $11.38 · $15,283
Loading xslF345X05/ownership.xml…